Table 3 Median ranks for different types of drugs in the combined evaluation set
| Drug type | Our approach | Hoehndorf’s approach | p-value |
|---|---|---|---|
| Non-targeted cancer therapies (chemotherapies) | 9.5 % | 25.8 % | p=0.023 |
| Targeted cancer drugs | 7.3 % | 56.4 % | p=0.015 |
| Non-cancer drugs | 13.3 % | 67.4 % | p=0.0006 |
